One Step Dementia Risk Test Kit

Key words:

Qankorey

Classification:

Products


Product Specifications

 

►First Globally
►Clinically approved
►Early screening: Risk alert of Dementia
►Non-invasive: Fresh midstream urine specimen
►Easy to use: 100 µL (4 drops) volume
►Fast: 10 Mins have result (Invalid after 15 minutes)

  

Product Name

One Step Dementia Risk Test Kit 

(Colloidal Gold Lateral Immunochromatography)

Certificate

CE, NMPA, MDA

Packing Specifications

1pc/box, 25pcs/box, 50pcs/box

Biomarker to Detect

This is to detect the Aβ concentration in the urine which is the major hallmark of Alzheimer’s Disease.

Intended Use

This product is an in vitro auxiliary screening device for risk alert of dementia (including but not limited to Alzheimer's disease). It may be used to evaluate brain health status and assist doctors to decide whether further tests are required.

Key Features

1. First Globally
2. Clinically approved
3. Early screening: Risk alert of Dementia
4. Non-invasive: Fresh midstream urine specimen
5. Easy to use: 100 µL (4 drops) volume
6. Fast: 10 Mins have result (Invalid after 15 minutes)

Overall Performance

Sensitivity: 79.14%       Specificity: 91.03%     Kappa Value: 0.704

Applicable People

Suitable for screening high-risk patients aged 45+

Product Advantages

Exclusive Core Technology

Self-developing of Aβ monoclonal antibody

Antibody-polymer sandwich method 

 

Product Application

It can be applied to the regular physical examination population over 45 years old;

Family history of dementia;

Memory impairment and suspected cognitive impairment;

Cardiovascular and cerebrovascular diseases and cerebrovascular injuries (stroke, cerebral hemorrhage, cerebral infarction, etc.);

Chronic diseases (hypertension, diabetes, hyperlipidemia, etc.), snoring and homocysteine deficiency;

Anxiety, depression, bad habits (smoking and drinking, lack of exercise in the middle of obesity, long-term lack of sleep, etc.);

Recommend Products


A biotechnology company focusing on key technologies for Alzheimer's disease (AD), a global medical challenge.

Explore more products